Women's attitude towards COVID-19 vaccination in pregnancy: A survey study in northern Italy

Int J Gynaecol Obstet. 2023 Jul;162(1):139-146. doi: 10.1002/ijgo.14506. Epub 2022 Oct 22.

Abstract

Objective: To investigate attitudes and risk perceptions towards the coronavirus disease 2019 (COVID-19) vaccine and reasons for hesitancy among pregnant women.

Methods: A prospective survey study was conducted at a University Maternity Department. Participants included any pregnant woman aged 18 years or older, able to understand the Italian language, who accessed the antenatal clinic for a prenatal appointment. The survey comprised questions about sociodemographic characteristics, pregnancy vaccination history, and perception of risk related to the immunization for the woman herself and her infant.

Results: A total of 538 women completed the questionnaire, 445 (82.7%) accepted COVID-19 vaccination. Women vaccinated against pertussis were three times more likely to take up the COVID-19 vaccine (odds ratio [OR] 3.19; 95% confidence interval [CI] 1.78-5.72). Having had COVID-19 during pregnancy (OR 0.24; 95% CI 0.11-0.54), and having a high-risk perception towards the immunization for the fetus (OR 0.18; 95% CI 0.09-0.34) were factors associated with vaccine hesitancy. Lack of safety data in pregnancy and the possibility of harm to the fetus were the main concerns.

Conclusion: A trusting and supportive relationship with the healthcare professional to address fears, and the transmission of evidence-based information, are pivotal to guide women through an informed choice. Understanding the determinants implicated in women's decision making might guide towards effective public health strategies to boost vaccine acceptance.

Keywords: COVID-19 vaccine; SARS-CoV-2; maternal attitude; risk perception; vaccination in pregnancy; vaccine acceptance; vaccine hesitancy.

MeSH terms

  • Attitude
  • COVID-19 Vaccines
  • COVID-19* / prevention & control
  • Female
  • Humans
  • Italy
  • Pregnancy
  • Prospective Studies
  • Vaccination

Substances

  • COVID-19 Vaccines